RFXAP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.138200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.578600E-01
Normal-vs-Stage2
1.427530E-02
Normal-vs-Stage3
6.446200E-02
Normal-vs-Stage4
1.405380E-01
Stage1-vs-Stage2
1.307600E-01
Stage1-vs-Stage3
7.962400E-02
Stage1-vs-Stage4
1.797170E-01
Stage2-vs-Stage3
3.551600E-01
Stage2-vs-Stage4
8.591400E-01
Stage3-vs-Stage4
4.909200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.428390E-01
Normal-vs-AfricanAmerican
5.069700E-02
Normal-vs-Asian
3.598400E-02
Caucasian-vs-AfricanAmerican
5.227200E-01
Caucasian-vs-Asian
4.969400E-01
AfricanAmerican-vs-Asian
8.450400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.432380E-01
Normal-vs-Female
9.190300E-02
Male-vs-Female
7.416800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.890000E-01
Normal-vs-Age(41-60Yrs)
1.755820E-01
Normal-vs-Age(61-80Yrs)
1.015780E-01
Normal-vs-Age(81-100Yrs)
4.916000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.837200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.790160E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.348000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.817200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.881200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.318200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.683860E-02
Normal-vs-Daily Drinker
7.725900E-02
Normal-vs-Weekly Drinker
2.896000E-02
Normal-vs-Occasional Drinker
2.109200E-01
Normal-vs-Social Drinker
5.135800E-01
Non Drinker-vs-Daily Drinker
8.355400E-01
Non Drinker-vs-Weekly Drinker
7.061400E-01
Non Drinker-vs-Occasional Drinker
4.882400E-01
Non Drinker-vs-Social Drinker
1.154430E-01
Daily Drinker-vs-Weekly Drinker
9.018600E-01
Daily Drinker-vs-Occasional Drinker
6.229600E-01
Daily Drinker-vs-Social Drinker
1.450620E-01
Weekly Drinker-vs-Occasional Drinker
6.853200E-01
Weekly Drinker-vs-Social Drinker
1.830380E-01
Occasional Drinker-vs-Social Drinker
3.741600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.752000E-01
Normal-vs-Grade 2
2.328200E-01
Normal-vs-Grade 3
3.353600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.311800E-02
Grade 1-vs-Grade 3
3.158200E-02
Grade 1-vs-Grade 4
2.752000E-01
Grade 2-vs-Grade 3
9.399800E-01
Grade 2-vs-Grade 4
2.328200E-01
Grade 3-vs-Grade 4
3.353600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.909800E-02
Normal-vs-NonDiabetic
1.201800E-01
Diabetic-vs-NonDiabetic
6.599400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.278600E-03
Normal-vs-NoPancreatitis
1.161820E-01
Pancreatitis-vs-NoPancreatitis
1.222790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.186400E-01
Normal-vs-N1
1.171630E-02
N0-vs-N1
4.706200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.713650E-01
Normal-vs-TP53-NonMutant
6.229800E-01
TP53-Mutant-vs-TP53-NonMutant
1.0266000000092E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
